HK1140969A1 - Prrsv vaccins based on gp5 proteins gp5 prrsv - Google Patents

Prrsv vaccins based on gp5 proteins gp5 prrsv

Info

Publication number
HK1140969A1
HK1140969A1 HK10107591.6A HK10107591A HK1140969A1 HK 1140969 A1 HK1140969 A1 HK 1140969A1 HK 10107591 A HK10107591 A HK 10107591A HK 1140969 A1 HK1140969 A1 HK 1140969A1
Authority
HK
Hong Kong
Prior art keywords
prrsv
vaccins
proteins
vaccins based
prrsv vaccins
Prior art date
Application number
HK10107591.6A
Other languages
English (en)
Chinese (zh)
Inventor
Byong-Kwan Kim
Original Assignee
Mj Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mj Biolog Inc filed Critical Mj Biolog Inc
Publication of HK1140969A1 publication Critical patent/HK1140969A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK10107591.6A 2007-04-30 2010-08-09 Prrsv vaccins based on gp5 proteins gp5 prrsv HK1140969A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91504907P 2007-04-30 2007-04-30
PCT/US2008/061962 WO2008134697A2 (fr) 2007-04-30 2008-04-30 Compositions à base de prrsv gp5 et procédés

Publications (1)

Publication Number Publication Date
HK1140969A1 true HK1140969A1 (en) 2010-10-29

Family

ID=39926318

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10107591.6A HK1140969A1 (en) 2007-04-30 2010-08-09 Prrsv vaccins based on gp5 proteins gp5 prrsv

Country Status (13)

Country Link
US (3) US8142788B2 (fr)
EP (2) EP2508203A1 (fr)
JP (1) JP2010526086A (fr)
KR (1) KR101673883B1 (fr)
CN (1) CN101578112A (fr)
CA (1) CA2685170C (fr)
DK (1) DK2152306T3 (fr)
ES (1) ES2526406T3 (fr)
HK (1) HK1140969A1 (fr)
MX (1) MX2009011638A (fr)
PL (1) PL2152306T3 (fr)
TW (2) TW201605471A (fr)
WO (1) WO2008134697A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201605471A (zh) * 2007-04-30 2016-02-16 Ｍｊ生物股份有限公司 豬繁殖與呼吸道症候群病毒（ｐｒｒｓｖ）ｇｐ５爲主之組成物及方法
WO2011153351A2 (fr) * 2010-06-02 2011-12-08 Virginia Tech Intellectual Properties, Inc. Vaccins vivants atténués inédits et vaccins sous-unitaires créés par recombinaison aléatoire de l'adn (« dna shuffling ») contre le virus du syndrome reproducteur et respiratoire porcin (vsrrp)
CA2859944C (fr) * 2011-12-30 2023-01-24 United Biomedical, Inc. Vaccin marqueur a base de peptides synthetiques et systeme diagnostic pour la maitrise efficace du syndrome dysgenesique et respiratoire porcin (sdrp)
CN104302316A (zh) * 2012-05-17 2015-01-21 佐蒂斯有限责任公司 在断奶之前对抗猪繁殖与呼吸综合征(prrs)病毒的有效疫苗接种
CN102796181A (zh) * 2012-06-20 2012-11-28 韩健宝 猪繁殖与呼吸综合征病毒的肽核酸及其应用
ES2682084T3 (es) 2014-02-07 2018-09-18 Mj Biologics, Inc. Proteínas y antígenos del virus de la diarrea epidémica porcina (VDEP)
US10280199B2 (en) 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
WO2016130569A1 (fr) 2015-02-09 2016-08-18 Mj Biologics, Inc. Composition contenant des antigènes du vdep et procédés de fabrication et d'utilisation de la composition
CA2957513A1 (fr) * 2014-08-08 2016-02-11 Idemitsu Kosan Co., Ltd. Agent de lutte contre le syndrome reproducteur et respiratoire porcin
MX2017016895A (es) * 2015-06-23 2018-04-10 Merial Inc Vectores virales recombinantes que contienen la proteina menor del virus del sindrome reproductor y respiratorio porcino (prrsv) y sus metodos de elaboracion y uso.
HRP20240344T1 (hr) 2017-06-02 2024-05-24 Ambrx, Inc. Postupci i pripravci za unapređenje produkcije proteina koji sadrže neprirodne aminokiseline
CN115785286B (zh) * 2022-12-05 2023-07-14 北京标驰泽惠生物科技有限公司 一种猪繁殖与呼吸综合征病毒的融合蛋白及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156111A1 (fr) 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Particules chimériques de type arterivirus
CA2620667A1 (fr) * 2005-08-30 2007-04-12 Board Of Regents Of The University Of Nebraska Procedes et compositions pour vaccination d'animaux avec des antigenes prrsv presentant une immunogenicite amelioree
WO2007064742A2 (fr) * 2005-11-29 2007-06-07 Iowa State University Research Foundation, Inc. Identification de determinants antigeniques protecteurs du virus du syndrome reproductif et respiratoire porcin et leurs utilisations
TW201605471A (zh) * 2007-04-30 2016-02-16 Ｍｊ生物股份有限公司 豬繁殖與呼吸道症候群病毒（ｐｒｒｓｖ）ｇｐ５爲主之組成物及方法

Also Published As

Publication number Publication date
PL2152306T3 (pl) 2015-07-31
US20090208520A1 (en) 2009-08-20
TW201605471A (zh) 2016-02-16
CA2685170A1 (fr) 2008-11-06
US20120141978A1 (en) 2012-06-07
JP2010526086A (ja) 2010-07-29
EP2508203A1 (fr) 2012-10-10
CA2685170C (fr) 2017-03-28
KR20100017504A (ko) 2010-02-16
MX2009011638A (es) 2010-03-26
WO2008134697A2 (fr) 2008-11-06
US8142788B2 (en) 2012-03-27
KR101673883B1 (ko) 2016-11-08
EP2152306A2 (fr) 2010-02-17
DK2152306T3 (en) 2014-12-08
ES2526406T3 (es) 2015-01-12
CN101578112A (zh) 2009-11-11
US20160256536A1 (en) 2016-09-08
EP2152306B1 (fr) 2014-11-26
WO2008134697A3 (fr) 2009-02-12
TW200914043A (en) 2009-04-01

Similar Documents

Publication Publication Date Title
HK1140969A1 (en) Prrsv vaccins based on gp5 proteins gp5 prrsv
HK1210413A1 (en) Oligosaccharide protein conjugates
EP1988922A4 (fr) Formulations de protéines
EP2157885A4 (fr) Articulation d'appuie-tete
EP2046930A4 (fr) Formulations à base de rhamnolipides
GB0703201D0 (en) Formulations
LT3118220T (lt) Baltymas
GB0711656D0 (en) Formulations
GB0605780D0 (en) Formulations
GB0716385D0 (en) Formulations
GB0712884D0 (en) Formulations
GB0618697D0 (en) Formulations
GB0809979D0 (en) Formulations
EP2155792A4 (fr) Conjugué d'oligonucléotide de la protéine g
ZA201000806B (en) Immunogenic streptococcus proteins
GB0711957D0 (en) Formulations
IL196646A0 (en) Stable lyophilized preparation
PL2007419T3 (pl) Szczepionka przeciwko mykoplazmie i PRRSV
GB0810232D0 (en) Formulations
GB0719231D0 (en) Protein
GB0618695D0 (en) Formulations
GB0724357D0 (en) Method for preparing protein conjugates
GB0724360D0 (en) Method for preparing protein conjugates
GB0705179D0 (en) Formulations
GB0720563D0 (en) Protein

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220430